11th DECEMBER , 2014
IBA has signed a collaboration agreement with Guangdong Hengju Medical Technologies Co. Limited to jointly install the first proton therapy system in South China. As a subsidiary of Guangdong Hengjian Investment Holding Co. Ltd., the financing and investment platform of the Guangdong provincial government, Guangdong Hengju Medical Technologies Co. Ltd is the first company in China to focus on the development and expansion of proton therapy in China u
nder the spirit of ‘Government Supported, Corporatized Management and Market Oriented.’
This new center, the 31st for IBA globally, will be located in the city of Guangzhou. The agreement, with a significant up-front payment, is worth approximately EUR 30 million to IBA. IBA will provide the new center with equipment from its Proteus®PLUS system, which will also be equipped with IBA’s next-generation Pencil Beam Scanning capability. The facility is set to open in the summer of 2017.
“We are the first Chinese company focusing on the development and expansion of proton therapy in China,” says Mr. Xiao Xue, Chairman, Guangdong Hengjian Investment Holding Co. Ltd. “The current proton therapy facility site enjoys full support from various Chinese government bodies, and is listed as a National Key Project. This first collaboration with IBA, the global leader in proton therapy, is very significant and is an important milestone for a future long-term partnership between both companies.”
“We are the first Chinese company focusing on the development and expansion of proton therapy in China,” says Mr. Xiao Xue, Chairman, Guangdong Hengjian Investment Holding Co. Ltd. “The current proton therapy facility site enjoys full support from various Chinese government bodies, and is listed as a National Key Project. This first collaboration with IBA, the global leader in proton therapy, is very significant and is an important milestone for a future long-term partnership between both companies.”
Mr. Wang Jian, Deputy General Manager at Guangdong Hengjian Investment Holding Co. Ltd., and Executive Director of Guangdong Hengju Medical Technologies Co. Limited, adds: “The signing of this contract will accelerate the development of the project, increase the rate of future developments and provide the chance to train our team and amplify the level of medical expertise in Guangdong Province.”
Read the full press release
Read the full press release
